World Library  
Flag as Inappropriate
Email this Article

Insulin glulisine

Article Id: WHEBN0009756329
Reproduction Date:

Title: Insulin glulisine  
Author: World Heritage Encyclopedia
Language: English
Subject: Insulin (medication), Exenatide, Insulin therapies, ATC code A10, NPH insulin
Publisher: World Heritage Encyclopedia

Insulin glulisine

Insulin glulisine
Clinical data
Trade names Apidra
  • US: C (Risk not ruled out)
Legal status
Routes of
CAS Registry Number  N
ATC code A10
DrugBank  Y
Chemical data
Formula C258H384N64O78S6
Molecular mass 5823 g/mol

Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid.[1] It was developed by Sanofi-Aventis and sold under the trade name Apidra.[2] When injected subcutaneously, it appears in the blood earlier than human insulin.[3] When used as a meal time insulin, the dose is given within 15 minutes before a meal or within 20 minutes after starting a meal.[4] Intravenous injections may also be used for extreme hyperglycemia, but must be performed under the supervision of a medical professional.[5]


  1. ^ DailyMed: apidra (insulin glulisine) injection, solution
  2. ^ Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag.  
  3. ^ Garnock-Jones, K. P.; Plosker, G. L. (2009). "Insulin Glulisine". Drugs 69 (8): 1035–1057.  
  4. ^ Insulin Glulisine
  5. ^ "Sanofi Prescription Products" (PDF). Sanofi. Retrieved 21 April 2012. 

External links

  • Apidra Homepage

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.